Sonic Healthcare Ltd
SHL
Company Profile
Business description
Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the UK, the second-largest in Belgium and New Zealand, and the third largest in the US. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second-largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 40% of group revenue in Australia and New Zealand, 25% in the US, and 35% in Europe.
Contact
225 George Street
Level 22, Grosvenor Place
SydneyNSW2000
AUST: +61 298555444
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
30 June 2025
Employees
41,000
Stocks News & Analysis
stocks
What we think of the 3 big winners of the ASX 100
Exploring the ASX companies who dominated the market this year
stocks
Ask the analyst: Why have Healius shares struggled so much?
Shares in Australia's second biggest pathology operator have floundered in recent years. Shane Ponraj thinks better days could be ahead.
personal-finance
Top 8 ASX dividend shares
These undervalued shares with moats have attractive and potentially growing dividends.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,203.90 | 28.80 | 0.35% |
CAC 40 | 7,573.76 | 37.50 | 0.50% |
DAX 40 | 22,271.67 | 29.22 | 0.13% |
Dow JONES (US) | 40,194.47 | 80.97 | 0.20% |
FTSE 100 | 8,417.34 | 2.09 | 0.02% |
HKSE | 21,971.96 | 8.78 | -0.04% |
NASDAQ | 17,343.16 | 39.78 | -0.23% |
Nikkei 225 | 35,839.99 | 134.25 | 0.38% |
NZX 50 Index | 12,098.89 | 81.05 | 0.67% |
S&P 500 | 5,522.67 | 2.54 | -0.05% |
S&P/ASX 200 | 7,997.10 | 28.90 | 0.36% |
SSE Composite Index | 3,288.41 | 6.65 | -0.20% |